Quest Diagnostics (NYSE:DGX) is a pivotal player in the healthcare industry, known for providing diagnostic testing, information, and services. The company offers a broad range of tests, from routine blood counts and cholesterol tests to complex gene-based and molecular testing. Quest Diagnostics serves patients, physicians, hospitals, health insurers, employers, and government agencies, helping to improve health outcomes and manage healthcare costs through their diagnostic insights. With a focus on innovation and quality, Quest Diagnostics continually invests in research and development to expand its test offerings and enhance patient experience. The company's objective is to empower better health decisions by delivering actionable insights. Quest Diagnostics is committed to making a positive impact on human health, reflected in its dedication to advancing diagnostic accuracy and accessibility for all.